Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 1997

View Archived Issues

Orally active antithrombotic agents described by Pfizer

Improved dolastatin derivatives prepared by BASF

Univ. of Pittsburgh claims inhibitors of farnesyltransferase/geranylgeranyltransferase

Thrombin inhibitors from Akzo Nobel

MS&D reports another series of potent and selective 5-HT1D agonists

Hoechst reveals new Na+/H+ exchange inhibitors

Kyowa Hakko discloses new calcitonin derivatives

Novel semisynthetic macrolides from Abbott

SKB discovers first selective human 5-HT1B receptor ligand

Novel anxiolytic and antidepressant buspirone analogue characterized

MDR-reversing agent from Mitsui Toatsu characterized in vitro and in vivo

FDA approves Hemagen Diagnostics' test for primary biliary cirrhosis

Cytel and Baxter enter research agreement for the development of ex vivo cancer therapy

Preclinical profile of MDL-27192

OrthoLogic and Sanofi to market sodium hyaluronate for osteoarthritis knee pain in the U.S.

Update on new injectable streptogramin antibiotic

Phase II results with Immunex's Flt3 ligand reported

NDA for entacapone scheduled for submission this month

Seikagaku's SOD preparation enters clinic in Europe

BMS to comarket antiemetic azasetron in Japan

More news on resveratrol

Lidak reports promising phase I/II data with melanoma vaccine

Baxter's DCLHb safe in acute ischemic stroke patients

Cambridge NeuroScience suspends phase III trial of Cerestat following interim data analysis

Novopharm Biotech issued U.S. patent for two human monoclonal antibodies

PEG-rHuMGDF enhances platelet recovery in cancer patients undergoing chemotherapy

Advisory committee recommends Taxol for KS

Agouron's acquisition of Alanex final

Meridian and Genpharm sign marketing agreement

BioSpecifics Technologies and Bausch & Lomb collaborate on glaucoma studies

IDEC and SmithKline Beecham suspend rheumatoid arthritis trial

New indication for enoxaparin recommended for approval

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026